Cargando…

Acceptability and adherence to Isoniazid preventive therapy in HIV-infected patients clinically screened for latent tuberculosis in Dar es Salaam, Tanzania

BACKGROUND: Proper adherence to isoniazid preventive therapy (IPT) may depend upon the results of tuberculosis (TB) screening test and patients’ understanding of their risk of developing active TB. We conducted a study to assess the acceptability, adherence and completion profile of IPT among HIV-in...

Descripción completa

Detalles Bibliográficos
Autores principales: Shayo, Grace A., Moshiro, Candida, Aboud, Said, Bakari, Muhammad, Mugusi, Ferdinand M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4549887/
https://www.ncbi.nlm.nih.gov/pubmed/26306511
http://dx.doi.org/10.1186/s12879-015-1085-7
_version_ 1782387372224151552
author Shayo, Grace A.
Moshiro, Candida
Aboud, Said
Bakari, Muhammad
Mugusi, Ferdinand M.
author_facet Shayo, Grace A.
Moshiro, Candida
Aboud, Said
Bakari, Muhammad
Mugusi, Ferdinand M.
author_sort Shayo, Grace A.
collection PubMed
description BACKGROUND: Proper adherence to isoniazid preventive therapy (IPT) may depend upon the results of tuberculosis (TB) screening test and patients’ understanding of their risk of developing active TB. We conducted a study to assess the acceptability, adherence and completion profile of IPT among HIV-infected patients who were clinically screened for latent TB Infection (LTBI). METHODS: A multicenter observational study was conducted in Dar es Salaam, Tanzania between February 2012 and March 2014. HIV-infected patients 10 years or older were clinically screened using a validated symptom-based screening tool to rule out active TB. Patients found to have no symptoms in the screening tool were given 300 mg of isoniazid (INH) daily for 6 months. Patients were followed up monthly at the National and Municipal hospital HIV clinics for INH refill and assessment of treatment adherence. Adherence was defined as consumption of 90 % or more of the monthly prescription of INH. RESULTS: All 1303 invited patients agreed to participate in the study. Of 1303 invited HIV-infected patients, 1283 (98.5 %) were recruited into the study. Twenty eight (2.2 %) did not complete treatment. Those who did not complete the treatment were exclusively adults aged 18 years or older, p = 0.302. The overall mean (±SD) adherence was 98.9 % (±2.9). Adherence level among children aged <18 years (92.2 %) was significantly lower than adherence level among patients aged 18–29 years (98.3 %), 30–49 years (98.8 %) and ≥ 50 years (98.5), p-value = 0.011. Sex, occupation, socio-economic status, duration of HIV infection, being on antiretroviral drugs (ARV) and duration of ARV use were not associated with adherence. CONCLUSION: IPT is highly accepted by HIV infected patients. Patients demonstrated high level of adherence to IPT. The level of adherence among children was slightly lower than that among adults. IPT non-completers were exclusively adults. Children might need adult supervision in taking IPT.
format Online
Article
Text
id pubmed-4549887
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45498872015-08-27 Acceptability and adherence to Isoniazid preventive therapy in HIV-infected patients clinically screened for latent tuberculosis in Dar es Salaam, Tanzania Shayo, Grace A. Moshiro, Candida Aboud, Said Bakari, Muhammad Mugusi, Ferdinand M. BMC Infect Dis Research Article BACKGROUND: Proper adherence to isoniazid preventive therapy (IPT) may depend upon the results of tuberculosis (TB) screening test and patients’ understanding of their risk of developing active TB. We conducted a study to assess the acceptability, adherence and completion profile of IPT among HIV-infected patients who were clinically screened for latent TB Infection (LTBI). METHODS: A multicenter observational study was conducted in Dar es Salaam, Tanzania between February 2012 and March 2014. HIV-infected patients 10 years or older were clinically screened using a validated symptom-based screening tool to rule out active TB. Patients found to have no symptoms in the screening tool were given 300 mg of isoniazid (INH) daily for 6 months. Patients were followed up monthly at the National and Municipal hospital HIV clinics for INH refill and assessment of treatment adherence. Adherence was defined as consumption of 90 % or more of the monthly prescription of INH. RESULTS: All 1303 invited patients agreed to participate in the study. Of 1303 invited HIV-infected patients, 1283 (98.5 %) were recruited into the study. Twenty eight (2.2 %) did not complete treatment. Those who did not complete the treatment were exclusively adults aged 18 years or older, p = 0.302. The overall mean (±SD) adherence was 98.9 % (±2.9). Adherence level among children aged <18 years (92.2 %) was significantly lower than adherence level among patients aged 18–29 years (98.3 %), 30–49 years (98.8 %) and ≥ 50 years (98.5), p-value = 0.011. Sex, occupation, socio-economic status, duration of HIV infection, being on antiretroviral drugs (ARV) and duration of ARV use were not associated with adherence. CONCLUSION: IPT is highly accepted by HIV infected patients. Patients demonstrated high level of adherence to IPT. The level of adherence among children was slightly lower than that among adults. IPT non-completers were exclusively adults. Children might need adult supervision in taking IPT. BioMed Central 2015-08-26 /pmc/articles/PMC4549887/ /pubmed/26306511 http://dx.doi.org/10.1186/s12879-015-1085-7 Text en © Shayo et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Shayo, Grace A.
Moshiro, Candida
Aboud, Said
Bakari, Muhammad
Mugusi, Ferdinand M.
Acceptability and adherence to Isoniazid preventive therapy in HIV-infected patients clinically screened for latent tuberculosis in Dar es Salaam, Tanzania
title Acceptability and adherence to Isoniazid preventive therapy in HIV-infected patients clinically screened for latent tuberculosis in Dar es Salaam, Tanzania
title_full Acceptability and adherence to Isoniazid preventive therapy in HIV-infected patients clinically screened for latent tuberculosis in Dar es Salaam, Tanzania
title_fullStr Acceptability and adherence to Isoniazid preventive therapy in HIV-infected patients clinically screened for latent tuberculosis in Dar es Salaam, Tanzania
title_full_unstemmed Acceptability and adherence to Isoniazid preventive therapy in HIV-infected patients clinically screened for latent tuberculosis in Dar es Salaam, Tanzania
title_short Acceptability and adherence to Isoniazid preventive therapy in HIV-infected patients clinically screened for latent tuberculosis in Dar es Salaam, Tanzania
title_sort acceptability and adherence to isoniazid preventive therapy in hiv-infected patients clinically screened for latent tuberculosis in dar es salaam, tanzania
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4549887/
https://www.ncbi.nlm.nih.gov/pubmed/26306511
http://dx.doi.org/10.1186/s12879-015-1085-7
work_keys_str_mv AT shayogracea acceptabilityandadherencetoisoniazidpreventivetherapyinhivinfectedpatientsclinicallyscreenedforlatenttuberculosisindaressalaamtanzania
AT moshirocandida acceptabilityandadherencetoisoniazidpreventivetherapyinhivinfectedpatientsclinicallyscreenedforlatenttuberculosisindaressalaamtanzania
AT aboudsaid acceptabilityandadherencetoisoniazidpreventivetherapyinhivinfectedpatientsclinicallyscreenedforlatenttuberculosisindaressalaamtanzania
AT bakarimuhammad acceptabilityandadherencetoisoniazidpreventivetherapyinhivinfectedpatientsclinicallyscreenedforlatenttuberculosisindaressalaamtanzania
AT mugusiferdinandm acceptabilityandadherencetoisoniazidpreventivetherapyinhivinfectedpatientsclinicallyscreenedforlatenttuberculosisindaressalaamtanzania